African pharmaceutical company Aspen reports a 5% increase in half-year profits

Aspen Pharmacare (APNJ.J), a new tab company in South Africa, announced a 5% increase in half-year earnings on Monday, driven by robust results in its manufacturing and commercial pharmaceuticals divisions.

The largest pharmaceutical company in Africa reported normalized headline earnings per share (HEPS) of 724.2 South African cents for the six months ending December 31, up from 688.3 cents in the previous comparable year. HEPS was up 17% on a constant currency basis.